Cargando…
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. However, the real benefits of the procedure are unclear. We infused a concentrated solution of ne...
Autores principales: | Curtò, Diego, Tomatis, Federica, Gastoldi, Sara, Galbusera, Miriam, Noris, Marina, Raimondi, Federico, Lorini, Ferdinando Luca, Falanga, Anna, Marchetti, Marina, Remuzzi, Giuseppe, Ruggenenti, Piero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278474/ https://www.ncbi.nlm.nih.gov/pubmed/34276706 http://dx.doi.org/10.3389/fimmu.2021.711915 |
Ejemplares similares
-
Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study
por: Ruggenenti, Piero, et al.
Publicado: (2021) -
ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to Therapy
por: Rurali, Erica, et al.
Publicado: (2013) -
SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation
por: Perico, Luca, et al.
Publicado: (2022) -
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19
por: Aiello, Sistiana, et al.
Publicado: (2022) -
Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant
por: Piras, Rossella, et al.
Publicado: (2020)